Category : Healthcare
Stem Cell Therapy Market in Asia-Pacific to 2018 Commercialization Supported by Favorable Government Policies, Strong Pipeline and Increased Licensing Activity
Synopsis GBI Research, the leading business intelligence provider, has released its latest research “Stem Cell Therapy Market in Asia-Pacific to 2018 - Commercialization Supported by Favorable Government Policies, Strong Pipeline and Increased Licensing Activity�. The report provides an in-depth analysis on stem cell research and development in India, China, Japan, South-Korea and Singapore. The report market analysis and forecasts for CABG, LSCT, Type 1 DM, Type 2 DM, Hearticellgram, Cerecellgram, Cartistem and Cupistem. The report also provides information on trends and pipelines. In addition to this, the report covers market drivers and challenges for stem cell research market. Browse Full Report http://www.aarkstore.com/healthcare/109512/stem-cell-therapymarket-in-asia-pacific-to-2018-commercialization-supported-byfavorable-government-policies
Summary GBI Research analysis finds the stem cell therapy market was valued at $545m in 2012, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 10% from 2012 to 2018, to attain a value of $972m in 2018. The market is poised for significant growth in the forecast period due to the anticipated launch of JCR Pharmaceuticals’ JR-031 (2014) in Japan and FCB Pharmicell’s Cerecellgram (CCG) (2015) in South Korea. The research is mainly in early stages, with the majority of the molecules being in early stages of development (Phase I/II and Phase II). Phase I/II and Phase II contribute 67% of the pipeline. Stem cell research is dominated by hospitals/universities/institutions, which contribute 63% of the molecules in the pipeline. The dominance of institutional research is attributable to uncertain therapeutic outcomes in stem cell research.The major companies conducting research in India include Reliance Life Sciences and Stempeutics Research Pvt Ltd, among others. The major institutions include PGIMER and AIIMS.
Table of contents 1.1 List of Tables 1.2 List of Figures Stem Cell Therapy Market in Asia-Pacific to 2018 - Introduction Stem Cell Therapy Market in Asia-Pacific to 2018 - Overview 3.1 Introduction 3.2 Market Characterization and Forecasts - Overview 3.2.1 Revenue Forecasts 3.2.2 Cost of Therapy 3.2.3 Allogeneic and Autologous Share
Related Reports ►
http://www.aarkstore.com/healthcare/111115/healthcare-regulatory-andreimbursement-landscape-norway
►
http://www.aarkstore.com/healthcare/111114/arthoscopic-devicesmarket-by-product-by-end-user
►
http://www.aarkstore.com/healthcare/111113/north-american-jointreconstruction-market
►
http://www.aarkstore.com/healthcare/111111/north-american-traumafixation-devices-market-by-types-by-end-users
►
http://www.aarkstore.com/healthcare/111108/north-americandermatology-treatment-devices-market
Stem Cell Therapy Market in Asia-Pacific to 2018 - Commercialization Supported by Favorable Government Policies, Strong Pipeline and Increased Licensing Activity
Published: Dec 2012 – 112 Pages GBI Research, the leading business intelligence provider, has released its latest research “Stem Cell Therapy Market in Asia-Pacific to 2018 - Commercialization Supported by Favorable Government Policies, Strong Pipeline and Increased Licensing Activity”
Price Format
Price
$ 3500
Site Licence
$ 7000
Enterprise wide Licence
$ 10500
Contact Us Office Office No. - 809, 8th Floor, B-Wing, Mahaavir Icon, Plot No.- 89 & 90, Sector-15, CBD-Belapur, Navi Mumbai – 400614, Maharashtra, India. Telefax No: +91 22 4127 6660 24/7 Online Support: +91 9987295242 General Inquiries : +91 - 22 2756 4953
You Can Visit http://www.aarkstore.com OR
Mail us at contact@aarkstore.com Blog :
http://www.aarkstore.com/blog/
Conference :
http://conference.aarkstore.com/
News :
http://www.aarkstore.com/news